Gayatri Bioorganics Limited Schedules Board Meeting on May 19, 2026 to Approve Audited FY26 Financial Results

1 min read     Updated on 12 May 2026, 11:05 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Gayatri Bioorganics Limited has notified BSE Limited of a Board of Directors meeting to be held on May 19, 2026, at its registered office in Hyderabad. The meeting's primary agenda is to consider and approve the audited financial results and audit report for the quarter and year ended March 31, 2026. The intimation, filed under Regulation 33, was submitted on May 12, 2026, and digitally signed by Whole-time Director Sreedhara Reddy Kanaparthy.

powered bylight_fuzz_icon
40152906

*this image is generated using AI for illustrative purposes only.

Gayatri Bioorganics Limited has informed BSE Limited of a forthcoming Board of Directors meeting scheduled for Tuesday, May 19, 2026. The meeting will be held at the company's registered office located at B3, 3rd Floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad – 500082, Telangana.

Board Meeting Agenda

The board meeting has been convened to address the following key items:

  • Audited Financial Results: To consider and approve the audited financial results of the company along with the audit report for the quarter and year ended March 31, 2026.
  • Other Business: Any other business with the permission of the Chair.

Meeting Details at a Glance

The following table summarises the key details of the scheduled board meeting:

Parameter: Details
Meeting Date: Tuesday, May 19, 2026
Intimation Date: May 12, 2026
Venue: B3, 3rd Floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad – 500082, Telangana
Agenda: Audited financial results for quarter and year ended March 31, 2026
Signatory: Sreedhara Reddy Kanaparthy, Whole-time Director

Regulatory Intimation

The intimation was submitted to BSE Limited in compliance with Regulation 33 of the applicable listing obligations. The communication was digitally signed by Sreedhara Reddy Kanaparthy, Whole-time Director (DIN: 09608890), on May 12, 2026.

Historical Stock Returns for Gayatri Bioorganics

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-22.00%-13.64%+23.40%+116.35%+128.35%

How have Gayatri Bioorganics' revenue and profitability trends evolved over the past few fiscal years, and what growth trajectory might the FY2026 annual results reveal?

Will the board consider declaring a dividend for FY2026 alongside the financial results, given the company's cash flow position and capital allocation strategy?

How is Gayatri Bioorganics positioned competitively in the bioorganics sector, and could the FY2026 results signal any strategic expansion or diversification plans?

Gayatri Bioorganics Limited Submits Q4FY26 Compliance Certificate to BSE

1 min read     Updated on 11 Apr 2026, 03:29 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Gayatri Bioorganics Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE Limited on 11.04.2026. The certificate, signed by Whole time Director Sreedhara Reddy Kanaparthy, covers the quarter ended 31.03.2026 and confirms proper dematerialization processes. Venture Capital and Corporate Investments Private Limited certified that securities were processed within regulatory timelines and depositories NSDL and CDSL were updated as registered owners within the prescribed 15-day period.

powered bylight_fuzz_icon
37447158

*this image is generated using AI for illustrative purposes only.

Gayatri bioorganics Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories & Participants) Regulations, 2018. The submission was made on 11.04.2026 for the quarter ended 31.03.2026.

Regulatory Compliance Details

The compliance certificate was submitted under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018. Sreedhara Reddy Kanaparthy, Whole time Director with DIN 09608890, signed and submitted the certificate to BSE Limited at P. J. Towers, Dalal Street, Mumbai.

Parameter: Details
Quarter Period: Ended 31.03.2026
Submission Date: 11.04.2026
Scrip Code: 524564
ISIN: INE052E01015
Signatory: Sreedhara Reddy Kanaparthy
Designation: Whole time Director

Dematerialization Process Certification

Venture Capital and Corporate Investments Private Limited, acting as the registrar and transfer agent, issued the compliance certificate on 03.04.2026. The certificate confirms adherence to prescribed dematerialization procedures and regulatory timelines.

The certification covers several key compliance areas:

  • Securities received for dematerialization have been mutilated and cancelled after due verification
  • Depositories have been updated as registered owners within the mandated 15-day period
  • Details of securities have been furnished to relevant stock exchanges
  • Both National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) records have been updated

Corporate Information

Gayatri Bioorganics Limited operates from its registered and corporate office located at B3, 3rd Floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad 500082, Telangana. The company holds CIN L24110TG1991PLC013512 and maintains its securities listing with BSE Limited under scrip code 524564.

Historical Stock Returns for Gayatri Bioorganics

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-22.00%-13.64%+23.40%+116.35%+128.35%

What operational or financial developments might Gayatri Bioorganics announce in their upcoming quarterly results for Q4 FY2026?

How might the bioorganics sector regulatory landscape evolve given SEBI's continued emphasis on depositories compliance?

Will Gayatri Bioorganics consider expanding their registrar and transfer agent partnerships beyond Venture Capital and Corporate Investments Private Limited?

More News on Gayatri Bioorganics

1 Year Returns:+116.35%